Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Pain is common and poorly managed in patients with advanced CKD, likely due to both under and over prescription of appropriate analgesics. Poorly managed pain contributes to patients’ poor quality of life and excessive health care use. There is tremendous variability within and between countries in prescribing patterns of analgesics, suggesting that factors other than patient characteristics account for these differences. This article discusses the pharmacologic management of acute and chronic pain in patients with advanced CKD, and the role analgesics, including opioids, play in the overall approach to pain management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Treatment of chronic non-cancer pain
Turk, D. C., Wilson, H. D., & Cahana, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60402-9 · Cited by 716
Prescription of long-acting opioids and mortality in patients with chronic noncancer pain
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2016) · JAMA · doi:10.1001/jama.2016.7789 · Cited by 369
Research works printed but not linked: 51
- Davison, 2014, Pain in chronic kidney disease: A scoping review, Semin Dial, 27, 188, 10.1111/sdi.12196 · DOI · Paper page
- Davison, 2006, Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients, Nephrol Dial Transplant, 21, 3189, 10.1093/ndt/gfl380 · DOI · Paper page
- Davison, 2005, The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients, J Pain Symptom Manage, 30, 465, 10.1016/j.jpainsymman.2005.05.013 · DOI · Paper page
- Cohen, 2007, Pain, sleep disturbance, and quality of life in patients with chronic kidney disease, Clin J Am Soc Nephrol, 2, 919, 10.2215/CJN.00820207 · DOI · Paper page
- Davison, 2010, Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients, J Pain Symptom Manage, 39, 477, 10.1016/j.jpainsymman.2009.08.008 · DOI · Paper page
- Weisbord, 2014, Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis, Clin J Am Soc Nephrol, 9, 1594, 10.2215/CJN.00220114 · DOI
- Barnard, 2006, Pain management in palliative care, S Afr Fam Pract, 48, 30, 10.1080/20786204.2006.10873406 · doi:10.1080/20786204.2006.10873406
- Barakzoy, 2006, Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease, J Am Soc Nephrol, 17, 3198, 10.1681/ASN.2006050477 · DOI · Paper page
- Wilkerson, 2016, The opioid epidemic in the United States, Emerg Med Clin North Am, 34, e1, 10.1016/j.emc.2015.11.002 · DOI · Paper page
- Rolita, 2013, Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults, J Am Geriatr Soc, 61, 335, 10.1111/jgs.12148 · DOI · Paper page
- Ishida, 2018, Opioid analgesics and adverse outcomes among hemodialysis patients, Clin J Am Soc Nephrol, 13, 746, 10.2215/CJN.09910917 · DOI
- Nagar, 2017, Opioid use in chronic pain patients with chronic kidney disease: A systematic review, Pain Med, 18, 1416, 10.1093/pm/pnw238 · DOI
- Kimmel, 2017, Opioid prescription, morbidity, and mortality in United States dialysis patients, J Am Soc Nephrol, 28, 3658, 10.1681/ASN.2017010098 · DOI · Paper page
- Evans, 2009, Acetaminophen, aspirin and progression of advanced chronic kidney disease, Nephrol Dial Transplant, 24, 1908, 10.1093/ndt/gfn745 · DOI · Paper page
- Wongrakpanich, 2018, A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly, Aging Dis, 9, 143, 10.14336/AD.2017.0306 · DOI · Paper page
- Moore, 1998, Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs, BMJ, 316, 333, 10.1136/bmj.316.7128.333 · DOI · Paper page
- Massey, 2010, Topical NSAIDs for acute pain in adults, Cochrane Database Syst Rev, 16, CD007402
- Sande, 2017, The use of opioids in cancer patients with renal impairment-a systematic review, Support Care Cancer, 25, 661, 10.1007/s00520-016-3447-0 · DOI
- Sarton, 2008, Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist/antagonist buprenorphine, Adv Exp Med Biol, 605, 486, 10.1007/978-0-387-73693-8_85 · DOI
- McQuay, 1996, A systematic review of antidepressants in neuropathic pain, Pain, 68, 217, 10.1016/S0304-3959(96)03140-5 · DOI · Paper page
- Atalay, 2013, Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and health-related quality of life in haemodialysis patients, Clin Drug Investig, 33, 401, 10.1007/s40261-013-0080-2 · DOI
- Ibrahim, 2017, Treatment of gabapentin toxicity with peritoneal dialysis: Assessment of gabapentin clearance, Am J Kidney Dis, 70, 878, 10.1053/j.ajkd.2017.05.010 · doi:10.1053/j.ajkd.2017.05.010
- Varney, Detecting aberrant opioid behavior in the emergency department: A prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R), Current Opioid Misuse Measure (COMM)™, and provider gestalt [published online ahead of print March 3, 2018], Intern Emerg Med
- 2016, “Weak” opioid analgesics. Codeine, dihydrocodeine and tramadol: No less risky than morphine, Prescrire Int, 25, 45
- Gunter, 2017, Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: A meta-analysis, J Clin Pharm Ther, 42, 27, 10.1111/jcpt.12484 · DOI
- Gibson, 1980, Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient, Clin Pharmacol Ther, 27, 665, 10.1038/clpt.1980.94 · DOI
- Raffa, 1992, Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic, J Pharmacol Exp Ther, 260, 275
- Smith, 2009, Opioid metabolism, Mayo Clin Proc, 84, 613, 10.1016/S0025-6196(11)60750-7 · DOI · Paper page
- Quigley, 2003, Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain, Palliat Med, 17, 185, 10.1191/0269216303pm658oa · doi:10.1191/0269216303pm658oa
- Kirvela, 1996, The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation, J Clin Anesth, 8, 13, 10.1016/0952-8180(95)00092-5 · DOI
- Foral, 2007, Oxycodone accumulation in a hemodialysis patient, South Med J, 100, 212, 10.1097/01.smj.0000242876.45747.0a · doi:10.1097/01.smj.0000242876.45747.0a
- Malhotra, 2015, The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy®, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment, J Opioid Manag, 11, 157, 10.5055/jom.2015.0265 · doi:10.5055/jom.2015.0265
- Lee, 2005, Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis, Palliat Med, 19, 259, 10.1191/0269216305pm1004cr · doi:10.1191/0269216305pm1004cr
- Samolsky Dekel, 2017, Dialyzability of oxycodone and its metabolites in chronic noncancer pain patients with end-stage renal disease, Pain Pract, 17, 604, 10.1111/papr.12483 · doi:10.1111/papr.12483
- Darwish, 2016, Effects of renal impairment and hepatic impairment on the pharmacokinetics of hydrocodone after administration of a hydrocodone extended-release tablet formulated with abuse-deterrence technology, Clin Pharmacol Drug Dev, 5, 141, 10.1002/cpdd.238 · doi:10.1002/cpdd.238
- Kreek, 1980, Methadone use in patients with chronic renal disease, Drug Alcohol Depend, 5, 197, 10.1016/0376-8716(80)90180-5 · DOI
- Hand, 1990, Buprenorphine disposition in patients with renal impairment: Single and continuous dosing, with special reference to metabolites, Br J Anaesth, 64, 276, 10.1093/bja/64.3.276 · DOI
- Chiang, 2003, Pharmacokinetics of the combination tablet of buprenorphine and naloxone, Drug Alcohol Depend, 70, S39, 10.1016/S0376-8716(03)00058-9 · DOI · Paper page
- Filitz, 2006, Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine, Eur J Pain, 10, 743, 10.1016/j.ejpain.2005.12.001 · DOI
- Dole, 1973, Methadone plasma level: Sustained by a reservoir of drug in tissue, Proc Natl Acad Sci USA, 70, 10, 10.1073/pnas.70.1.10 · DOI
- Perlman, 2013, Intradialytic clearance of opioids: Methadone versus hydromorphone, Pain, 154, 2794, 10.1016/j.pain.2013.08.015 · doi:10.1016/j.pain.2013.08.015
- Joh, 1998, Nondialyzability of fentanyl with high-efficiency and high-flux membranes, Anesth Analg, 86, 447, 10.1213/00000539-199802000-00049 · doi:10.1213/00000539-199802000-00049
- Opdal, 2015, Effects of hemodialysis on methadone pharmacokinetics and QTc, Clin Ther, 37, 1594, 10.1016/j.clinthera.2015.04.009 · doi:10.1016/j.clinthera.2015.04.009
- Furlan, 1999, Methadone is poorly removed by haemodialysis, Nephrol Dial Transplant, 14, 254, 10.1093/ndt/14.1.254 · DOI
- Randinitis, 2003, Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function, J Clin Pharmacol, 43, 277, 10.1177/0091270003251119 · DOI · Paper page
- Bockbrader, 2010, A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin, Clin Pharmacokinet, 49, 661, 10.2165/11536200-000000000-00000 · DOI · Paper page
- Randinitis, 2003, Pharmacokinetics of pregabalin in subjects with various degrees of renal function, J Clin Pharmacol, 43, 277, 10.1177/0091270003251119 · DOI · Paper page
- Lee, 1980, Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis, Clin Toxicol, 17, 429, 10.3109/15563658008989993 · doi:10.3109/15563658008989993
- Gupta, 1999, Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline, Br J Clin Pharmacol, 48, 71, 10.1046/j.1365-2125.1999.00973.x · DOI
- Sandoz, 1984, Metabolism of amitriptyline in patients with chronic renal failure, Eur J Clin Pharmacol, 26, 227, 10.1007/BF00630290 · doi:10.1007/bf00630290
- Bell, 2009, Ketamine for chronic non-cancer pain, Pain, 141, 210, 10.1016/j.pain.2008.12.003 · DOI · Paper page
Cited by
Epidemiology of haemodialysis outcomes
Bello, A. K., Okpechi, I. G., Osman, M. A., Cho, Y., Htay, H., Jha, V., Wainstein, M., & Johnson, D. W. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00542-7 · Cited by 631
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“Regarding kidney function, NSAIDs, inhibitors of COX, should be avoided in patients with renal impairment.(88) On the contrary, therapeutic doses of paracetamol are generally safe and do not lead to acute renal failure in patients with renal impairment.”
BackgroundAlchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
Davison, S. N., Rathwell, S., George, C., Hussain, S. T., Grundy, K., & Dennett, L. (2020) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358120910329 · Cited by 25
Self-citation
Metadata
- Authors
- Davison, S. N.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2019-03-04
- Volume
- 14
- Issue
- 6
- Pages
- 917-931
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2919576556
- Cited by
- 123
- References
- 4
- FWCI
- 22.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure. https://app.cochat.ai/papers/10.2215/cjn.05180418
- The paper
- Davison, S. N. (2019). Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.05180418
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.